BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 5263293)

  • 61. The induction of tumours in the guinea-pig with methylcholanthrene and diethylnitrosamine and their propagation in vivo and in vitro.
    Dale MM; Easty GC; Tchao R; Desai H; Andjargholi M
    Br J Cancer; 1973 Jun; 27(6):445-50. PubMed ID: 4352789
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cell-mediated cytotoxicity of adherent and non-adherent mouse lymph node cells sensitized in vitro against tumour-associated antigens of syngenetic methylcholanthrene-induced sarcomas.
    Indrová M; Bubeník J
    Folia Biol (Praha); 1979; 25(2):137-41. PubMed ID: 456694
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Multiple antigenic specificities within primary 3-methylcholanthrene-induced rat sarcomas and metastases.
    Pimm MV; Embleton MJ; Baldwin RW
    Int J Cancer; 1980 May; 25(5):621-9. PubMed ID: 6154664
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Macrophage content and immunogenicity of C57BL/6J and BALB/cByJ methylcholanthrene-induced sarcomas.
    Evans R; Lawler EM
    Int J Cancer; 1980 Dec; 26(6):831-5. PubMed ID: 7216549
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Immunogenic efficacy of various syngeneic tumor cell preparations.
    Natale N; Reiner J; Southam CM
    Cancer; 1971 Nov; 28(5):1118-25. PubMed ID: 5125660
    [No Abstract]   [Full Text] [Related]  

  • 66. Immunospecific regression of methylcholanthrene fibrosarcoma with the use of neuraminidase.
    Simmons RL; Rios A; Lundgren G; Ray PK; McKhann CF; Haywood GR
    Surgery; 1971 Jul; 70(1):38-46. PubMed ID: 5092115
    [No Abstract]   [Full Text] [Related]  

  • 67. Chemical specificity of carcinogen-induced tolerance to homotransplantation.
    Fox H; Bock FG
    J Natl Cancer Inst; 1967 May; 38(5):789-95. PubMed ID: 6071672
    [No Abstract]   [Full Text] [Related]  

  • 68. Cross-reacting tumor associated transplantation antigen on primary 3-methylcholanthrene-induced BALB/c sarcomas.
    Coggin JH
    Mol Biother; 1989; 1(4):223-8. PubMed ID: 2818874
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The soluble antigens of BALB/c sarcoma Meth-A: a relationship between a serologically defined tumor-specific surface antigen (TSSA) and the tumor-associated transplantation antigen (TATA).
    DuBois GC; Appella E; Law LW; DeLeo AB; Old LJ
    Transplant Proc; 1981 Dec; 13(4):1765-73. PubMed ID: 6173944
    [No Abstract]   [Full Text] [Related]  

  • 70. Prevention of tumor growth in an "immunologically privileged site" by adoptive transfer of tumor-specific transplantation immunity.
    Futrell JW; Albright NL; Myers GH
    J Surg Res; 1972 Feb; 12(2):62-9. PubMed ID: 5012043
    [No Abstract]   [Full Text] [Related]  

  • 71. Fetal antigens shared as transplantation rejection antigens on chemically induced mouse and hamster sarcomas.
    Coggin JH; Adkinson L; Anderson NG
    Cancer Res; 1980 May; 40(5):1568-73. PubMed ID: 6768448
    [No Abstract]   [Full Text] [Related]  

  • 72. Tumour specific immunogenicity of methylcholanthrene-induced sarcoma cells after incubation in neuraminidase.
    Currie GA; Bagshawe KD
    Br J Cancer; 1969 Mar; 23(1):141-9. PubMed ID: 5768430
    [No Abstract]   [Full Text] [Related]  

  • 73. Purification and biochemical properties of tumor-associated transplantation antigens from methylcholanthrene-induced murine sarcomas.
    DuBois GC; Law LW; Appella E
    Proc Natl Acad Sci U S A; 1982 Dec; 79(24):7669-73. PubMed ID: 6961442
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Mouse rosette forming cells in transplantation immunity].
    Brondz BD; Eliseeva LS; Kotomina IF; Egorova SG
    Tsitologiia; 1974 Jan; 16(1):74-81. PubMed ID: 4142816
    [No Abstract]   [Full Text] [Related]  

  • 75. EFFECT ON TUMOUR GROWTH IN SYNGENEIC RECIPIENTS OF ANTIBODIES AGAINST TUMOUR-SPECIFIC ANTIGENS IN METHYLCHOLANTHRENE-INDUCED MOUSE SARCOMAS.
    MOLLER G
    Nature; 1964 Nov; 204():846-7. PubMed ID: 14235705
    [No Abstract]   [Full Text] [Related]  

  • 76. Tumor-secific immunity to chemically induced tumors. Evidence for immunologic specificity and shared antigenicity in lymphocyte responses to soluble tumor antigens.
    Frbes JT; Nakaw Y; Smith RT
    J Exp Med; 1975 May; 141(5):1181-200. PubMed ID: 47896
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cell-bound immunity to autologous and syngeneic mouse tumors induced by methylcholanthrene and plastic discs.
    Hellström I; Hellström KE
    Science; 1967 May; 156(3777):981-3. PubMed ID: 6023270
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Immunospecific regression of methylcholanthrene fibrosarcoma using neuraminidase. 3. Synergistic effect of BCG and neuraminidase treated tumor cells.
    Simmons RL; Rios A
    Ann Surg; 1972 Aug; 176(2):188-94. PubMed ID: 4562008
    [No Abstract]   [Full Text] [Related]  

  • 79. Tumor-associated antigens in isoantigenic variants of a 3-methylcholanthrene-induced sarcoma.
    Oth D; Berebbi M; Meyer G
    J Natl Cancer Inst; 1975 Oct; 55(4):903-8. PubMed ID: 52721
    [TBL] [Abstract][Full Text] [Related]  

  • 80. STUDIES ON SPECIFIC TRANSPLANTATION RESISTANCE TO POLYOMA-VIRUS-INDUCED TUMORS. IV. STABILITY OF THE POLYOMA CELL ANTIGEN.
    SJOEGREN HO
    J Natl Cancer Inst; 1964 Mar; 32():661-6. PubMed ID: 14130678
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.